Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
International Journal of Cancer|September 25, 2018
KDM5 demethylases and their role in cancer cell chemoresistanceJohana Plch, Jan Hrabeta, Tomas EckschlagerBiomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 23, 2015
Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1Helena Doktorova, Jan Hrabeta, Mohamed Ashraf Khalil, et al.International Journal of Molecular Sciences|July 4, 2017
Histone Deacetylase Inhibitors as Anticancer DrugsTomas Eckschlager, Johana Plch, Marie Stiborova, et al.Cancer Genetics and Cytogenetics|December 8, 2009
Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristinePavel Prochazka, Jan Hrabeta, Ales Vícha, et al.Oncology Reports|March 6, 2026
KDM5D expression is lost in cisplatin‑resistant neuroblastoma cellsNatalia Podhorska, Jan Hrabeta, Marie Belhajova, et al.Current Protein & Peptide Science|August 20, 2009
Metallothioneins and cancerTomas Eckschlager, Vojtech Adam, Jan Hrabeta, et al.Neuro Endocrinology Letters|January 29, 2013
Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cellsTomas Groh, Jan Hrabeta, Jitka Poljakova, et al.Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 23, 2013
Histone deacetylase inhibitors in cancer therapy. A reviewJan Hrabeta, Marie Stiborova, Vojtech Adam, et al.Journal of Molecular Medicine (Berlin, Germany)|September 18, 2016
Zinc and zinc-containing biomolecules in childhood brain tumorsJan Hrabeta, Tomas Eckschlager, Marie Stiborova, et al.Anti-Cancer Agents in Medicinal Chemistry|November 21, 2015
Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing ChemoresistanceJan Hrabeta, Vojtech Adam, Tomas Eckschlager, et al.Pageof 4